Publicaciones en colaboración con investigadores/as de Hospital Clínico San Carlos de Madrid (6)

2022

  1. Identification of ALK-positive patients with advanced NSCLC and real-world clinical experience with crizotinib in Spain (IDEALK study)

    Lung Cancer, Vol. 173, pp. 83-93

  2. Pembrolizumab in combination with gemcitabine for patients with HER2-negative advanced breast cancer: GEICAM/2015–04 (PANGEA-Breast) study

    BMC Cancer, Vol. 22, Núm. 1

  3. Sapanisertib plus Fulvestrant in Postmenopausal Women with Estrogen Receptor-Positive/HER2-Negative Advanced Breast Cancer after Progression on Aromatase Inhibitor

    Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 28, Núm. 6, pp. 1107-1116

2021

  1. Pembrolizumab plus gemcitabine in the subset of triple-negative advanced breast cancer patients in the geicam/2015-04 (Pangea-breast) study

    Cancers, Vol. 13, Núm. 21

1997

  1. A metastatic muscle mass as the first manifestation of renal-cell cancer. A case report and review of the literature

    Anales de medicina interna (Madrid, Spain : 1984), Vol. 14, Núm. 4, pp. 184-186

  2. Quimioterapia del cancer de ovario en estadios I y II de la FIGO

    Revisiones en Cancer, Vol. 10, Núm. 5, pp. 222-228